Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)

Abstract Background Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. Meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Forum Infectious Diseases 2023-03, Vol.10 (3), p.ofad089-ofad089
Hauptverfasser: Shahrir, Shahida, Crothers, Kristina, McGinnis, Kathleen A, Chan, Kwun C G, Baeten, Jared M, Wilson, Sarah M, Butt, Adeel A, Pisani, Margaret A, Baldassarri, Stephen R, Justice, Amy, Williams, Emily C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page ofad089
container_issue 3
container_start_page ofad089
container_title Open Forum Infectious Diseases
container_volume 10
creator Shahrir, Shahida
Crothers, Kristina
McGinnis, Kathleen A
Chan, Kwun C G
Baeten, Jared M
Wilson, Sarah M
Butt, Adeel A
Pisani, Margaret A
Baldassarri, Stephen R
Justice, Amy
Williams, Emily C
description Abstract Background Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. Methods We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003–2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0–365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH. Results The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994–1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040–1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036–1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004–1.009]). Conclusions In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking. Receipt of smoking cessation medications doubled among patients with and without HIV in the VA between 2003 and 2018. Although annual rates of receiving medications were comparable for both populations, there is considerable room for improvement.
doi_str_mv 10.1093/ofid/ofad089
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10034589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A773982297</galeid><oup_id>10.1093/ofid/ofad089</oup_id><sourcerecordid>A773982297</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-c5f4554440540d1eb2f863adc6e0264828055a6f786f8056afa82f4cc7afe53f3</originalsourceid><addsrcrecordid>eNp9kU9vFCEYxifGxjZtb54NN2viVmBgBk5ms1HbpEZjtR4JhZdddAbGgTHZm99BP6GfRPaPTb0YEngCz_vjhaeqHhN8TrCsX0TnbZm0xUI-qI5oTcVMSN4-vKcPq9OUvmCMCcEct_JRdVg3shGykUfVrw9gwA8ZRYeu-_jVhyVaQEo6-xjQW7DebGVC8z6Ws_cQhw7QZ59XSAe7FXHK6GLqdUCXfT-FaMF54yGYNbrx45SQDyivAN1AhlFvUMvtNXEVx4yu82TX6IxiXP_-8ZNiIp6dVAdOdwlO9-tx9en1q4-Li9nVuzeXi_nVzDDB8sxwxzhnjGHOsCVwS51oam1NA5g2TFCBOdeNa0Xjimy004I6ZkyrHfDa1cfVyx13mG57sAZCHnWnhtH3elyrqL369yT4lVrG74qUZhkXshDO9oQxfpsgZdX7ZKDrdIA4JUVbSVrcEEyL9XxnXeoOlA8uFqQpw0LvTQzl08r-vG1rKSiVbSl4viswY0xpBHfXGMFqk77apK_26Rf7k_uPuTP_zboYnu4McRr-j_oDz0e7mQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791706102</pqid></control><display><type>article</type><title>Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)</title><source>DOAJ Directory of Open Access Journals</source><source>Access via Oxford University Press (Open Access Collection)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>PubMed Central</source><creator>Shahrir, Shahida ; Crothers, Kristina ; McGinnis, Kathleen A ; Chan, Kwun C G ; Baeten, Jared M ; Wilson, Sarah M ; Butt, Adeel A ; Pisani, Margaret A ; Baldassarri, Stephen R ; Justice, Amy ; Williams, Emily C</creator><creatorcontrib>Shahrir, Shahida ; Crothers, Kristina ; McGinnis, Kathleen A ; Chan, Kwun C G ; Baeten, Jared M ; Wilson, Sarah M ; Butt, Adeel A ; Pisani, Margaret A ; Baldassarri, Stephen R ; Justice, Amy ; Williams, Emily C</creatorcontrib><description>Abstract Background Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. Methods We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003–2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0–365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH. Results The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994–1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040–1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036–1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004–1.009]). Conclusions In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking. Receipt of smoking cessation medications doubled among patients with and without HIV in the VA between 2003 and 2018. Although annual rates of receiving medications were comparable for both populations, there is considerable room for improvement.</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofad089</identifier><identifier>PMID: 36968969</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Analysis ; Drug therapy ; Drugs ; Drugstores ; Efavirenz ; Electronic records ; Evidence-based medicine ; HIV (Viruses) ; Major ; Medical research ; Medicine, Experimental ; Nicotine ; Pharmacy ; Smoking cessation programs ; Veterans</subject><ispartof>Open Forum Infectious Diseases, 2023-03, Vol.10 (3), p.ofad089-ofad089</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023</rights><rights>The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</rights><rights>COPYRIGHT 2023 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-c5f4554440540d1eb2f863adc6e0264828055a6f786f8056afa82f4cc7afe53f3</citedby><cites>FETCH-LOGICAL-c484t-c5f4554440540d1eb2f863adc6e0264828055a6f786f8056afa82f4cc7afe53f3</cites><orcidid>0000-0002-5578-854X ; 0000-0003-0139-5502</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034589/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034589/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,1586,1606,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36968969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shahrir, Shahida</creatorcontrib><creatorcontrib>Crothers, Kristina</creatorcontrib><creatorcontrib>McGinnis, Kathleen A</creatorcontrib><creatorcontrib>Chan, Kwun C G</creatorcontrib><creatorcontrib>Baeten, Jared M</creatorcontrib><creatorcontrib>Wilson, Sarah M</creatorcontrib><creatorcontrib>Butt, Adeel A</creatorcontrib><creatorcontrib>Pisani, Margaret A</creatorcontrib><creatorcontrib>Baldassarri, Stephen R</creatorcontrib><creatorcontrib>Justice, Amy</creatorcontrib><creatorcontrib>Williams, Emily C</creatorcontrib><title>Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)</title><title>Open Forum Infectious Diseases</title><addtitle>Open Forum Infect Dis</addtitle><description>Abstract Background Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. Methods We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003–2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0–365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH. Results The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994–1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040–1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036–1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004–1.009]). Conclusions In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking. Receipt of smoking cessation medications doubled among patients with and without HIV in the VA between 2003 and 2018. Although annual rates of receiving medications were comparable for both populations, there is considerable room for improvement.</description><subject>Analysis</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Drugstores</subject><subject>Efavirenz</subject><subject>Electronic records</subject><subject>Evidence-based medicine</subject><subject>HIV (Viruses)</subject><subject>Major</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Nicotine</subject><subject>Pharmacy</subject><subject>Smoking cessation programs</subject><subject>Veterans</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kU9vFCEYxifGxjZtb54NN2viVmBgBk5ms1HbpEZjtR4JhZdddAbGgTHZm99BP6GfRPaPTb0YEngCz_vjhaeqHhN8TrCsX0TnbZm0xUI-qI5oTcVMSN4-vKcPq9OUvmCMCcEct_JRdVg3shGykUfVrw9gwA8ZRYeu-_jVhyVaQEo6-xjQW7DebGVC8z6Ws_cQhw7QZ59XSAe7FXHK6GLqdUCXfT-FaMF54yGYNbrx45SQDyivAN1AhlFvUMvtNXEVx4yu82TX6IxiXP_-8ZNiIp6dVAdOdwlO9-tx9en1q4-Li9nVuzeXi_nVzDDB8sxwxzhnjGHOsCVwS51oam1NA5g2TFCBOdeNa0Xjimy004I6ZkyrHfDa1cfVyx13mG57sAZCHnWnhtH3elyrqL369yT4lVrG74qUZhkXshDO9oQxfpsgZdX7ZKDrdIA4JUVbSVrcEEyL9XxnXeoOlA8uFqQpw0LvTQzl08r-vG1rKSiVbSl4viswY0xpBHfXGMFqk77apK_26Rf7k_uPuTP_zboYnu4McRr-j_oDz0e7mQ</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Shahrir, Shahida</creator><creator>Crothers, Kristina</creator><creator>McGinnis, Kathleen A</creator><creator>Chan, Kwun C G</creator><creator>Baeten, Jared M</creator><creator>Wilson, Sarah M</creator><creator>Butt, Adeel A</creator><creator>Pisani, Margaret A</creator><creator>Baldassarri, Stephen R</creator><creator>Justice, Amy</creator><creator>Williams, Emily C</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5578-854X</orcidid><orcidid>https://orcid.org/0000-0003-0139-5502</orcidid></search><sort><creationdate>20230301</creationdate><title>Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)</title><author>Shahrir, Shahida ; Crothers, Kristina ; McGinnis, Kathleen A ; Chan, Kwun C G ; Baeten, Jared M ; Wilson, Sarah M ; Butt, Adeel A ; Pisani, Margaret A ; Baldassarri, Stephen R ; Justice, Amy ; Williams, Emily C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-c5f4554440540d1eb2f863adc6e0264828055a6f786f8056afa82f4cc7afe53f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analysis</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Drugstores</topic><topic>Efavirenz</topic><topic>Electronic records</topic><topic>Evidence-based medicine</topic><topic>HIV (Viruses)</topic><topic>Major</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Nicotine</topic><topic>Pharmacy</topic><topic>Smoking cessation programs</topic><topic>Veterans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shahrir, Shahida</creatorcontrib><creatorcontrib>Crothers, Kristina</creatorcontrib><creatorcontrib>McGinnis, Kathleen A</creatorcontrib><creatorcontrib>Chan, Kwun C G</creatorcontrib><creatorcontrib>Baeten, Jared M</creatorcontrib><creatorcontrib>Wilson, Sarah M</creatorcontrib><creatorcontrib>Butt, Adeel A</creatorcontrib><creatorcontrib>Pisani, Margaret A</creatorcontrib><creatorcontrib>Baldassarri, Stephen R</creatorcontrib><creatorcontrib>Justice, Amy</creatorcontrib><creatorcontrib>Williams, Emily C</creatorcontrib><collection>Access via Oxford University Press (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open Forum Infectious Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shahrir, Shahida</au><au>Crothers, Kristina</au><au>McGinnis, Kathleen A</au><au>Chan, Kwun C G</au><au>Baeten, Jared M</au><au>Wilson, Sarah M</au><au>Butt, Adeel A</au><au>Pisani, Margaret A</au><au>Baldassarri, Stephen R</au><au>Justice, Amy</au><au>Williams, Emily C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)</atitle><jtitle>Open Forum Infectious Diseases</jtitle><addtitle>Open Forum Infect Dis</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>10</volume><issue>3</issue><spage>ofad089</spage><epage>ofad089</epage><pages>ofad089-ofad089</pages><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract Background Nicotine replacement therapy, bupropion, and varenicline are smoking cessation medications (SCMs) shown to be similarly effective in people with and without human immunodeficiency virus (PWH and PWoH, respectively), although rates of receipt of these medications are unknown. Methods We identified patients in the Veterans Aging Cohort Study with electronic health record-documented current smoking using clinical reminder data for tobacco use (2003–2018). We measured receipt of SCMs using Veterans Affairs pharmacy data for outpatient prescriptions filled 0–365 days after current smoking documentation. We used log-linear, Poisson-modified regression models to evaluate the relative risk (RR) for receiving SCM by human immunodeficiency virus (HIV) status, the annual rate of receipt, and rate difference among PWH relative to PWoH. Results The sample included 92 632 patients (29 086 PWH), reflecting 381 637 documentations of current smoking. From 2003 to 2018, the proportion receiving SCMs increased from 15% to 34% for PWH and from 17% to 32% among PWoH. There was no statistical difference in likelihood of receiving SCM by HIV status (RR, 1.010; 95% confidence interval [CI], .994–1.026). Annual rates of receiving SCM increased for PWH by 4.3% per year (RR, 1.043; 95% CI, 1.040–1.047) and for PWoH by 3.7% per year (RR, 1.037; 95% CI, 1.036–1.038; rate difference +0.6% [RR, 1.006; 95% CI, 1.004–1.009]). Conclusions In a national sample of current smokers, receipt of SCM doubled over the 16-year period, and differences by HIV status were modest. However, fewer than 35% of current smokers receive SCM annually. Efforts to improve SCM receipt should continue for both groups given the known dangers of smoking. Receipt of smoking cessation medications doubled among patients with and without HIV in the VA between 2003 and 2018. Although annual rates of receiving medications were comparable for both populations, there is considerable room for improvement.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>36968969</pmid><doi>10.1093/ofid/ofad089</doi><orcidid>https://orcid.org/0000-0002-5578-854X</orcidid><orcidid>https://orcid.org/0000-0003-0139-5502</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open Forum Infectious Diseases, 2023-03, Vol.10 (3), p.ofad089-ofad089
issn 2328-8957
2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10034589
source DOAJ Directory of Open Access Journals; Access via Oxford University Press (Open Access Collection); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); PubMed Central
subjects Analysis
Drug therapy
Drugs
Drugstores
Efavirenz
Electronic records
Evidence-based medicine
HIV (Viruses)
Major
Medical research
Medicine, Experimental
Nicotine
Pharmacy
Smoking cessation programs
Veterans
title Receipt of Smoking Cessation Medications Among People With and Without Human Immunodeficiency Virus in the Veterans Aging Cohort Study (2003–2018)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T23%3A06%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Receipt%20of%20Smoking%20Cessation%20Medications%20Among%20People%20With%20and%20Without%20Human%20Immunodeficiency%20Virus%20in%20the%20Veterans%20Aging%20Cohort%20Study%20(2003%E2%80%932018)&rft.jtitle=Open%20Forum%20Infectious%20Diseases&rft.au=Shahrir,%20Shahida&rft.date=2023-03-01&rft.volume=10&rft.issue=3&rft.spage=ofad089&rft.epage=ofad089&rft.pages=ofad089-ofad089&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofad089&rft_dat=%3Cgale_pubme%3EA773982297%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2791706102&rft_id=info:pmid/36968969&rft_galeid=A773982297&rft_oup_id=10.1093/ofid/ofad089&rfr_iscdi=true